Clinical trial
Effect of 4 Weeks of Oral 6-bromotryptophan on Safety, Pharmacokinetics and Efficacy in Metabolic Syndrome Individuals (2022)
NCT05971524 is registered in ClinicalTrials.gov with Nordin Hanssen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of 4 Weeks of Oral 6-bromotryptophan on Safety, Pharmacokinetics and Efficacy in Metabolic Syndrome Individuals (2022)
- Lead sponsor
- Nordin Hanssen
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- May 4, 2023
- Completion date
- February 1, 2025
- Enrollment
- 36 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.